Literature DB >> 11549794

Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: clinical correlations.

V Boneschi1, L Brambilla, E Berti, S Ferrucci, M Corbellino, C Parravicini, S Fossati.   

Abstract

BACKGROUND: Kaposi's sarcoma is a multifocal lympho-angioproliferative disease that appears in elderly subjects of Mediterranean origin (classical form), young Africans and immunodepressed patients (as a result of organ transplantation or AIDS). In 1994, DNA sequences of a new human herpesvirus, called HHV-8, were detected in skin lesions and peripheral blood of patients with AIDS-related Kaposi's sarcoma by confirmational display analysis and polymerase chain reaction.
OBJECTIVE: As HHV-8 in peripheral blood mononuclear cells is detected in about 50% of Mediterranean Kaposi's sarcoma patients and its presence fluctuates in time in the same patient, maybe its detection correlates with the clinical behaviour of the disease.
METHODS: By using routine and nested polymerase chain reaction we evaluated the presence of HHV-8-specific DNA sequences in the skin lesions, perilesional healthy skin and peripheral blood mononuclear cells of a group of 40 HIV-negative patients with Mediterranean Kaposi's sarcoma.
RESULTS: HHV-8 DNA sequences have been found in 40/40 (100%) lesional skin of Mediterranean Kaposi's sarcoma, in 35/40 (85%) perilesional apparently normal skin and in 24/40 (60%) peripheral blood monuclear cell samples. The results of polymerase chain reaction on peripheral blood monuclear cells were positive in 41% of the patients with slowly evolving disease as opposed to 74% of those with rapidly evolving disease, and in 47.6% of the patients with stage I-II disease as opposed to 73.6% of those with stage III-IV.
CONCLUSION: The detection of HHV-8 in peripheral blood monuclear cells seems to correlate with the more aggressive stages and the rapid evolution behaviour of Mediterranean Kaposi's sarcoma. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549794     DOI: 10.1159/000051697

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

1.  Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Authors:  Diana Palmeri; Sophia Spadavecchia; Kyla Driscoll Carroll; David M Lukac
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer.

Authors:  Wei Bu; Kyla Driscoll Carroll; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

3.  HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma.

Authors:  Roberta Mancuso; Renato Biffi; Marilena Valli; Monica Bellinvia; Athanasia Tourlaki; Tourlaki Athanasia; Silvia Ferrucci; Lucia Brambilla; Serena Delbue; Pasquale Ferrante; Carmine Tinelli; Mario Clerici
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

Review 5.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

6.  STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Christine A King; Xiaofan Li; Arturo Barbachano-Guerrero; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

7.  AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?

Authors:  Francesco M Solivetti; Fulvia Elia; Alessandra Latini; Carlo Cota; Paola Cordiali-Fei; Aldo Di Carlo
Journal:  J Exp Clin Cancer Res       Date:  2011-04-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.